Medical University of Bialystok (MUB) is a renowned, dynamically expanding institution of higher education, distinguished among Polish academic centers. MUB has a unique and strong position in the life science research/education in Poland having the status of a Leading National Research Centre (KNOW) in medicine/health science in Poland for the years 2012-2017. According to the data of the last (2013) scientific ranking of the Ministry of Science and Higher Education of Poland the Faculty of Pharmacy with the Division of Laboratory Medicine of MUB was the highest ranked research institute in the field of life science with the only A+ score and the Faculty of Medicine with the Division of Dentistry and Division of Medical Education in English received the highest score among all medical faculties in Poland. MUB has established in 2012 Centre for Innovative Research, which comprises Mossakowski Medical Research Centre, Polish Academy of Sciences, CenStat, UHasselt and CEMBIO, USP-CEU. The purpose of CIR is a search for new markers for early detection of civilization diseases. The project includes search for biomarkers of individualized targeted therapy of these diseases. Innovative high-throughput technologies like: genomics, transcriptomics, epigenomics, proteomics, metabolomics and modern methods of medical imaging (hybrid PET/MRI) are used.
The University offers very modern infrastructure for scientific research. Center of Experimental Medicine is most advanced center specialized in running the animal laboratory and conducting experimental studies on laboratory animals. It provides a unique base for basic research, preclinical and implementation for national and international entities, possess Good Laboratory Practice (GLP) certificate to conduct experimental research on animals in the fields of toxicity studies and pharmacokinetic studies. Euroregional Laboratory of Pharmaceutical Analysis is the first such facility in the country that provides the ability to control drugs and formulation derived from cross-border exchange and evaluation of qualitative and quantitative toxic substances in medicinal preparations, food and biological material. Collaborate with facility run by representatives of police, fire department and border guards. Euroregional Centre of Pharmacy is a highly specialized pharmaceutical-analytical unit, which introduces modern research techniques to the daily scientific work. ECP conducts research in collaboration with various national and international centers, they involve, among others, drug discovery of synthetic and natural, evaluation mechanism of drug action, toxicity profile and pharmacokinetic-pharmacodynamic drug form technology and medical diagnostics. Centre for Clinical Research (opened in April 2015) - new facilities for clinical research in the area of metabolic, cardiovascular, neurodegenerative diseases and oncology - the project funded by Polish Government as a part of ”Reconstruction and Development of the University Hospital in Bialystok” (total budget 506 million PLN). It possess equipment for the high-throughput genomics/transcriptomics (HiSeq 4000), proteomics and metabolomics (Orbitrap MS) (2015) - funded by the Regional Operational Programme for Podlasie Region (33 million PLN). Centre for Bioinformatics and Data Analysis (opened in November 2015) - infrastructural grant funded from Operational Programme Development of Eastern Poland (European Regional Development Fund) (19 million PLN). Laboratory of Molecular Imaging and Technology Transfer - SME company (owned by MUB) at the Bialystok Science and Technology Park (BSTP) is an operator of the most modern PET-MRI hybrid for molecular imaging.